Patent ID: 8048869

Claim:
A method of hormone replacement therapy, comprising administering to a person in need of such a therapy an effective amount of an estrogenic component selected from the group consisting of: substances represented by the following formula in which formula R 1 , R 2 , R 3 , R 4 independently are a hydrogen atom, a hydroxyl group or an alkoxy group with 1-5 carbon atoms; each of R 5 , R 6 , R 7 is a hydroxyl group; and no more than 3 of R 1 , R 2 , R 3 , R 4 are hydrogen atoms; derivatives of these substances wherein the hydrogen atom of at least one of the hydroxyl groups in said formula has been substituted by an acyl radical of a hydrocarbon carboxylic, sulfonic or sulfamic acid of 1-25 carbon atoms; tetrahydrofuranyl; tetrahydropyranal; or a straight or branched chain glycosidic residue containing 1-20 glycosidic units per residues; and mixtures thereof, said composition containing virtually no progestogen, anti-progestin or gonadotropin releasing hormone wherein said method does not comprise administering progestogen, anti-progestin or gonadotropin releasing hormone.